Literature DB >> 2044717

Rubella in Guipuzcoa (Basque Country, Spain) a four-year serosurvey.

E Pérez Trallero1, G Cilla Eguiluz, M Dorronsoro Iraeta, J R Saenz Dominguez.   

Abstract

Since the early 1980s, Spain has practiced mass vaccination of preschool children and selective vaccination of prepubertal girls. Estimated vaccination coverage in the province of Guipúzcoa (Basque Country) in recent years is about 95% (confirmed minimums of 89% for preschool children and 87.5% for 11 to 12 year-old girls). From the seroepidemiological study we could deduce that there was extensive circulation of wild rubella virus until recently (72-75% of unvaccinated girls 10 to 11 years-old had rubella antibody). More than 98% of the population at risk, represented in this study by 13,564 women (67% of all who bore children over a four-year period), possessed rubella antibodies. In the course of the study period the number of subjects (puerperal women and children) susceptible to infection declined. In spite of this favorable situation, the seroepidemiological study disclosed certain gaps that should be corrected to meet the targets for the European Region of the Expanded Programme on Immunization, and to achieve the goal of elimination of wild rubella virus in the area.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2044717     DOI: 10.1007/bf00237364

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  7 in total

1.  Clinical rubella with virus transmission to the fetus in a pregnant woman considered to be immune.

Authors:  L Hornstein; U Levy; A Fogel
Journal:  N Engl J Med       Date:  1988-11-24       Impact factor: 91.245

2.  Congenital rubella affecting an infant whose mother had rubella antibodies before conception.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1981-04-11

3.  Rubella and congenital rubella surveillance, 1983.

Authors:  N M Williams; S R Preblud
Journal:  MMWR CDC Surveill Summ       Date:  1984

4.  Persistent rubella infection and rubella-associated arthritis.

Authors:  J K Chantler; D K Ford; A J Tingle
Journal:  Lancet       Date:  1982-06-12       Impact factor: 79.321

5.  Outcome of asymptomatic infection with rubella virus during pregnancy.

Authors:  J E Cradock-Watson; M K Ridehalgh; M J Anderson; J R Pattison
Journal:  J Hyg (Lond)       Date:  1981-10

6.  Viremia, virus excretion, and antibody responses after challenge in volunteers with low levels of antibody to rubella virus.

Authors:  S O'Shea; J M Best; J E Banatvala
Journal:  J Infect Dis       Date:  1983-10       Impact factor: 5.226

7.  Postpartum rubella immunization: association with development of prolonged arthritis, neurological sequelae, and chronic rubella viremia.

Authors:  A J Tingle; J K Chantler; K H Pot; D W Paty; D K Ford
Journal:  J Infect Dis       Date:  1985-09       Impact factor: 5.226

  7 in total
  1 in total

1.  Seroepidemiology, morbidity and vaccination strategies against rubella infection. Eight years experience in Oltrepò Pavese.

Authors:  C Pelissero; C Marena; F Aguzzi; M Bevilacqua; F Rebasti
Journal:  Eur J Epidemiol       Date:  1993-05       Impact factor: 8.082

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.